Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

BACKGROUND: Bevacizumab and the antimetabolites capecitabine and gemcitabine have been shown to improve outcomes when added to taxanes in patients with metastatic breast cancer. The primary aims of this trial were to determine whether the addition of capecitabine or gemcitabine to neoadjuvant chemot...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Bear, Harry D., Tang, Gong, Rastogi, Priya, Geyer, Charles E., Robidoux, André, Atkins, James N., Baez-Diaz, Luis, Brufsky, Adam M., Mehta, Rita S., Fehrenbacher, Louis, Young, James A., Senecal, Francis M., Gaur, Rakesh, Margolese, Richard G., Adams, Paul T., Gross, Howard M., Costantino, Joseph P., Swain, Sandra M., Mamounas, Eleftherios P., Wolmark, Norman
Format: Artigo
Sprog:Inglês
Udgivet: 2012
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3401076/
https://ncbi.nlm.nih.gov/pubmed/22276821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1111097
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker